Gene Query: MUC5AC

Dataset Description Geneva Score
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 207.21
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 176.52
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 150.7
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 142.44
TGF-β promotes genomic instability after loss of RUNX3 126.08
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 125.36
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 113.48
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 107.14
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 89.7
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 88.55
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 86.18
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 72.69
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 70.89
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 69.95
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 69.95
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 67.28
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 67.28
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 64.02
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 61.49
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 60.89
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 58.52
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 57.64
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 56.96
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 56.94
Expression data from miR340 overexpressing human A549 cells 53.34
METTL3 promotes translation in human cancer cells 53.1
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 52.52
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 48.13
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 47.96
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 46.27
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 45.56
Total RNA sequencing of WT intestinal orgaonids. 44.84
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 44.44
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 42.17
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 38.81
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 38.41
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 38.15
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 38.0
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 36.77
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 35.89
A549 cells and MSR-A549 cells 35.89
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 35.69
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 35.5
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 35.27
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 34.5
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 33.82
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 32.04
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 31.38
Transcriptome analysis of human lung epithelial cells 31.33
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 31.2
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 31.16
Genetic-to-epigenetic Therapy for Pancreatic Cancer 30.4
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 30.1
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 29.76
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 29.47
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 29.33
Effect of Influenza virus infection on lncRNA expression in A549 cells 29.31
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 28.22
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 27.86
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 27.58
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 27.21
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 27.21
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 25.9
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 25.08
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 23.55
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 23.53
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 23.53
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 21.99
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 21.96
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 21.22
Transcriptome profiling of A2M treated A549 Cell Line Samples 20.48
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 20.21
Comparison of microRNA Profiling Platforms 19.87
Comparison of microRNA Profiling Platforms (HTS) 19.87
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 19.55
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 19.45
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 18.38
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 18.38
PTHrP overexpression in MCF7 cells 18.29
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 18.07
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 17.88
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 17.61
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 17.48
circNFIB suppresses lymphatic metastasis of pancreatic cancer 15.46
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 14.31
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 13.97
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 13.61
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 13.22
Persistence of stem cell metabolism in cancers as a failure of differentiation 13.06
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 12.75
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.49
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 12.32
Finding missing proteins from epigenetically manipulated human cells 12.17
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 12.1
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 11.96
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 11.66
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 11.57
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 10.89
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 10.84
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.83
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 10.81
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 10.6
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.55
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 10.27
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 10.22
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 10.05
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 10.05
High-Throughput Kinetic Analysis of Fractional Killing 9.59
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.43
RNA-seq of SCLC PDX models treated with EP 9.3
Overexpression of NFIB and YBX1 in MCF-7 cells 9.24
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 9.0
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 9.0
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 8.98
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.88
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 8.6
Rorc disruption in human FG pancreatic cancer cells 8.31
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 8.11
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 7.95
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 7.78
RNA seq analysis of human Fetal and adult derived Enterospheres 7.65
RNA seq_PDX2_SHP099 7.61
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.61
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.49
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.49
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.48
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 7.4
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 7.25
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.25
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 7.24
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.21
HEK293 Heat-shock experiment 7.15
Reassessment of Exosome Composition 7.11
The gene expression profiles of gallbladder cancer 6.98
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 6.67
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 6.58
ML29755 RNA-seq data 6.57
Gene expression profile in breast cancer cell lines using RNA sequencing 6.27
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.26
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 6.21
RNA sequencing of human pancreatic cancer cell lines 6.0
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 5.8
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.75
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 5.72
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 5.7
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 5.7
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.65
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.39
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.3
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 4.87
Total RNA sequencing of APC mutant and wt colonic organoids 4.6
Reprogrammed myeloid cell transcriptomes in NSCLC 4.55
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.54
snRNAs as regulators of alternative splicing 4.41
RNA-sequencing 4.37
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.33
Differential Gene Expression between MCF10A and MCF7 cells 4.27
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.26
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 4.22
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 4.22
RNA-seq analysis of breast cancer 4.1
RNA-seq analysis and shRNA screen of breast cancer 4.1
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.93
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.92
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.92
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.91
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 3.81
The role of the Calcium-Sensing receptor in colorectal cancer 3.79
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.72
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.72
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 3.45
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.34
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 3.26
RNAseq of Breast cancer PDX samples 3.23
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.21
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 3.16
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.07
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.07
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 3.03
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.03
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.01
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.01
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.98
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 2.95
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 2.91
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 2.91
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.84
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.84
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 2.82
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 2.81
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 2.81
mRNA sequencing of oropharyngeal cancer cell lines 2.78
RNA m5C Methylation in breast cancer using MeRIP-Seq 2.65
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.64
The expression profiles of GBC liver metastasis 2.62
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.61
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.61
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 2.58
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 2.56
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.53
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 2.52
Selective expression of long non-coding RNAs in a breast cancer cell progression model 2.52
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.51
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.48
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.46
Expression patterns in chronic thromboembolic pulmonary hypertension 2.42
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.37
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 2.32
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.3
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.26
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.13
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.12
Nrf2 regulated genes in A549 cells 2.1
Identification of Nrf2 regulated genes by RNA sequencing 2.1
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.01
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.98
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 1.98
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 1.98
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.96
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.87
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.84
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.84
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.83
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.82
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.81
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.79
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 1.79
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.78
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.74
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.73
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.71
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.7
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.7
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.66
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 1.61
circRNA-sequencing 1.57
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.57
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.57
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.55
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.55
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.55
Gene expression profiling in metabolically heterogeneous human lung tumors 1.53
NR2F2 study 1.43
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.43
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.4
Gene expression of collecting duct carcinoma of the kidney 1.39
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.39
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.38
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.37
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.35
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.34
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.31
Gene expression alterations of pancreatic intraepithlial neoplasia 1.29
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.24
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.24
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.22
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.2
Transcriptome analysis reveals differential splicing events in IPF lung tissue 1.14
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 1.12
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.09
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.09
Identification of a LIF-responsive replication-competent human β cell 1.09
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.08
CDK12 mediated transcriptional regulation in U2OS cells 1.05
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 1.04
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.04
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.03
Transcriptional responses of melanoma cells to BRAF inhibition 1.03
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 1.0
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 1.0
Exploring ILF2 regulatory genes by next-generation sequencing 0.95
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.95
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.93
Investigate A2M treatment on human prostate cancer and mouse liver 0.93
Investigate A2M treatment on human prostate cancer xenograft in mice 0.93
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.9
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.89
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 0.88
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.86
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.84
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.84
Illumina Total RNA-seq in HeLa 0.84
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.79
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.79
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.79
Overexpression and knockdown experiment for circCSNK1G3 0.78
Enhancer activation during EGF response 0.77
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.75
Gene expression analysis of human adenomas. 0.75
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 0.73
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.72
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.71
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.71
RNA seq comparison between scrambled and shGRP78 cells 0.69
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.69
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.68
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.68
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 0.65
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.65
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.64
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.63
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.63
RNA-sequencing of human tendon after injury 0.62
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.62
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.6
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.59
Genome-wide analysis of Dengue virus 2 infected cells 0.58
Identification of expressed and conserved human non-coding RNAs 0.58
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 0.56
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.54
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.53
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.53
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.52
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.52
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.52
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.52
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.5
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 0.49
RNA-seq analysis of control and Myc-induced U2OS cells 0.49
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 0.48
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.44
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.44
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.44
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.44
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.43
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 0.43
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.43
NHLRC1 re-expression in cancer cells 0.42
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.42
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.42
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 0.4
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 0.4
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 0.4
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.4
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.4
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.39
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.38
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.38
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.38
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 0.37
T47D RNA-seq and ChrRNA-seq data 0.37
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.37
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.37
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.37
Exploring the RNA landscape of endothelial exosomes 0.35
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.35
RNA-sequencing in irradiated and normal A549 cells. 0.34
Transposon-based construction of strand-specific RNA-seq libraries 0.33
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.32
Effect of Hotair overexpression in human breast cancer cell lines 0.32
Noncoding regions are the main source of targetable tumor-specific antigens 0.32
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.3
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.3
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.3
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.3
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.29
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.29
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.29
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.29
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.28
Electronic cigarettes 0.28
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.28
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.28
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 0.28
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 0.28
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.28
Gene expression activation in CLL mediated by MSCs contact 0.28
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 0.27
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.27
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.27
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 0.26
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.26
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 0.26
siRNA-mediated knockdown 0.26
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 0.25
Gene expression patterns define the hepatocyte-like cells derived by different strategies 0.24
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 0.24
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.23
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.23
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.23
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.23
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.23
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.23
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 0.23
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 0.23
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.23
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.22
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.22
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 0.22
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 0.21
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.21
Hepatic transcriptome of pediatric hepatoblastoma. 0.21
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.21
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 0.21
RNAseq analysis of ruxolitinib treated breast cancers 0.2
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 0.2
Transcriptome analysis of kidney organoids 0.2
BASP1 modifies the Tamoxifen response 0.19
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.19
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.19
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.19
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.19
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.18
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.18
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.18
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.18
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.17
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.17
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 0.17
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.17
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.17
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.17
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.16
Engineering Patient-Specific Tissue Implants 0.16
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.16
Non-coding regions are the main source of tumor-specific antigens 0.16
Non-coding regions are the main source of tumor-specific antigens [human] 0.16
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.16
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.16
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.16
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.16
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.15
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.15
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.15
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.15
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.14
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.14
mRNA-sequencing of breast cancer subtypes and normal tissue 0.14
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.14
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.14
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 0.14
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.14
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 0.14
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.14
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 0.14
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.14
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.14
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.13
Expression profiling of converted and control dermal BJ fibroblasts 0.11
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.11
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.11
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.11
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.11
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.11
Determination of tRNA aminoacylation levels by high throughput sequencing 0.11
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.1
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.1
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.1
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.1
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.1
Transciptomic profiling of human fetal lung samples 0.09
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.09
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.08
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.08
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.08
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.08
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 0.08
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 0.08
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.08
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.08
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.07
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.07
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.07
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.07
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.06
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.06
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.06
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.06
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.05
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.05
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.05
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.05
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.05
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.04
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.04
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 0.04
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.04
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.04
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.04
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 0.04
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.04
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.03
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.03
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.03
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.03
RNA-sequencing of formalin fixed human primary melanoma tissue 0.03
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.03
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.03
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.02
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.02
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.02
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.02
Fusion discovery in breast cancer cell line 0.01
The DNA methylation landscape of human melanoma 0.01
The DNA methylation landscape of human melanoma [RNA-Seq] 0.01
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.0
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.0
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.0
RNA-seq data 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation